Remedy with SR18662 significantly lowers growth and proliferation of CRC cells. SR18662 exhibits improved efficacy in minimizing viability of numerous CRC mobile strains. Movement cytometry analysis pursuing SR18662 remedy reveals an increase in cells captured in both S or G2/M phases of the cell cy